dupilumab 200 MG in 1.14 mL Prefilled Syringe
- RxCUI
- 2099300
- RxNorm name
- dupilumab 200 MG in 1.14 mL Prefilled Syringe
- Display name
- dupilumab 200 MG in 1.14 mL Prefilled Syringe
- Full name
- dupilumab 200 MG in 1.14 mL Prefilled Syringe
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:59
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761055 | Dupixent | dupilumab | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dupixent | DUPILUMAB | Sanofi-Aventis U.S. LLC | 595f437d-2729-40bb-9c62-c8ece1f82780 | 2026-04-22 | Warnings, Adverse reactions | 2099300 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 595f437d-2729-40bb-9c62-c8ece1f82780 | dupilumab 200 MG in 1.14 mL Prefilled Syringe | PSN | 56 | These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT ® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017 | 20260422 |
| 595f437d-2729-40bb-9c62-c8ece1f82780 | 1.14 ML dupilumab 175 MG/ML Prefilled Syringe | SCD | 56 | These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT ® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017 | 20260422 |
| 595f437d-2729-40bb-9c62-c8ece1f82780 | dupilumab 200 MG per 1.14 ML Prefilled Syringe | SY | 56 | These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT ® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017 | 20260422 |